Questa pagina è stata tradotta automaticamente e l'accuratezza della traduzione non è garantita. Si prega di fare riferimento al Versione inglese per un testo di partenza.

Recupero post-affaticamento nei giovani atleti: confronto tra terapia TECAR e cicloergometro

Effetti immediati e a breve termine della terapia TECAR e dell'ergometro da ciclo sul recupero dopo affaticamento in giovani atleti: uno studio randomizzato controllato

The goal of this clinical trial is to compare two recovery methods after fatigue in young athletes. It aims to find out if tecar therapy (TECAR) or cycle ergometer exercise can improve recovery after intense physical activity and help athletes return to their normal performance more quickly.

The main questions it aims to answer are:

Does TECAR or cycle ergometer improve physical performance after fatigue?

Do these methods reduce muscle pain and soreness after fatigue?

Researchers will compare TECAR with active recovery using a cycle ergometer to see which method is more effective.

Participants will:

Perform a series of jumps to induce fatigue

Be randomly assigned to one of the recovery methods

Complete physical tests before and after fatigue

Undergo simple measurements of muscle condition and pain

Report their level of effort and muscle soreness

Panoramica dello studio

Descrizione dettagliata

This study is a randomized controlled trial designed to evaluate and compare the effectiveness of two recovery strategies following exercise-induced fatigue in young athletes: tecar therapy (TECAR) and active recovery (usual care) using a cycle ergometer.

Exercise-induced fatigue can reduce physical performance and increase muscle soreness, which may negatively affect athletic performance and increase injury risk. This study aims to compare the effects of two commonly used recovery strategies on physical performance, muscle mechanical properties, and perceived recovery.

Participants will be physically active young athletes over 18 years of age, familiar with plyometric or jump-based activities. They will be recruited through convenience sampling. Individuals with recent musculoskeletal injuries or those who have performed intense physical exercise within 24 hours prior to testing will be excluded.

All procedures will be conducted in a controlled environment by trained personnel following a standardized protocol. After providing informed consent, participants will undergo baseline assessments, including physical performance tests, measurements of muscle mechanical properties, and subjective perception of effort and muscle soreness.

A standardized warm-up will be performed prior to testing, consisting of low-intensity aerobic activity for approximately five minutes, aiming to reach a moderate level of perceived exertion.

Participants will then complete a fatigue protocol consisting of repeated drop jumps from a fixed height of approximately 0.6 meters. The protocol will be organized into multiple sets with controlled rest intervals between repetitions and sets in order to induce acute neuromuscular fatigue in a standardized manner.

Immediately after the fatigue protocol, the same assessments will be repeated to evaluate the acute effects of fatigue.

Participants will then be randomly assigned to one of the two recovery interventions:

TECAR: application of capacitive and resistive electric transfer using radiofrequency energy for 20 minutes

Active recovery (usual care): continuous cycling on a cycle ergometer at low-to-moderate intensity for 20 minutes, reflecting standard recovery practices commonly used in athletic settings

Following the assigned recovery intervention, all assessments will be repeated to evaluate recovery effects.

In addition, subjective measures of muscle soreness and perceived effort will be collected at 12 and 24 hours after the intervention to assess short-term recovery.

Outcome measures will include objective indicators of physical performance and muscle mechanical properties, assessed using a handheld myotonometer, as well as pressure pain threshold (a measure of sensitivity to pressure), and subjective measures related to perceived effort and muscle soreness.

Statistical analysis will include descriptive statistics and inferential analysis to compare differences between groups and over time. A two-way analysis of variance (group × time) will be used to evaluate the effects of the recovery intervention and measurement time points, including potential interaction effects. Statistical significance will be set at p < 0.05.

This study aims to provide evidence on the comparative effectiveness of TECAR and active recovery strategies, contributing to the optimization of recovery protocols in athletic populations.

Tipo di studio

Interventistico

Iscrizione (Stimato)

48

Fase

  • Non applicabile

Contatti e Sedi

Questa sezione fornisce i recapiti di coloro che conducono lo studio e informazioni su dove viene condotto lo studio.

Contatto studio

  • Nome: Sandra Alcaraz Clariana, PhD PT
  • Numero di telefono: +34625434043
  • Email: m72alcls@uco.es

Backup dei contatti dello studio

  • Nome: Lourdes García Luque, PhD PT
  • Numero di telefono: +34627366324
  • Email: z12galul@uco.es

Luoghi di studio

    • Córdoba
      • Córdoba, Córdoba, Spagna, 14011
        • Reclutamento
        • Physiobalance
        • Contatto:
          • Sandra Alcaraz Clariana, PhD PT
          • Numero di telefono: +34625434043
          • Email: m72alcls@uco.es
        • Contatto:
          • Lourdes García Luque, PhD PT
          • Numero di telefono: +34627366324
          • Email: z12galul@uco.es
        • Investigatore principale:
          • Sandra Alcaraz Clariana, PhD PT
        • Sub-investigatore:
          • Lourdes García Luque, PhD PT

Criteri di partecipazione

I ricercatori cercano persone che corrispondano a una certa descrizione, chiamata criteri di ammissibilità. Alcuni esempi di questi criteri sono le condizioni generali di salute di una persona o trattamenti precedenti.

Criteri di ammissibilità

Età idonea allo studio

18 anni e precedenti (Adulto, Adulto più anziano)

Accetta volontari sani

Sì

Sessi ammissibili allo studio

Tutto

Descrizione

Inclusion Criteria:

  • Adults aged 18 years or older
  • Engaging in regular physical activity
  • Experience with sports involving jumping or plyometric exercises

Exclusion Criteria:

  • Performed intense physical exercise within 24 hours before the study
  • Planned to perform intense physical exercise within 24 hours after the study
  • Presence of muscle soreness at the beginning of the study
  • Musculoskeletal injury in the previous 6 months

Piano di studio

Questa sezione fornisce i dettagli del piano di studio, compreso il modo in cui lo studio è progettato e ciò che lo studio sta misurando.

Come è strutturato lo studio?

Dettagli di progettazione

  • Scopo principale: Trattamento
  • Assegnazione: Randomizzato
  • Modello interventistico: Assegnazione parallela
  • Mascheramento: Doppio

Armi e interventi

Gruppo di partecipanti / Arm
Intervento / Trattamento
Sperimentale: TECAR

Participants assigned to this group will receive tecar therapy (TECAR) for 20 minutes. TECAR will be applied using the capacitive mode only, combining manual mobile application and fixed automatic application. The intervention will be applied after a standardized fatigue protocol consisting of repeated drop jumps, which is identical for all participants.

TECAR is applied using capacitive radiofrequency energy for 20 minutes following a standardized fatigue protocol. The intervention is delivered using capacitive mode only, combining manual mobile application and fixed automatic application over the quadriceps region to promote recovery after exercise-induced fatigue.

Altri nomi:
  • Terapia elettrica capacitiva e resistiva. Terapia a radiofrequenza
Comparatore attivo: Active recovery (usual care)

Participants assigned to this group will perform active recovery (usual care) consisting of continuous cycling on a cycle ergometer for 20 minutes at low intensity, not exceeding 2-3 on a 0-10 rating of perceived exertion scale. The intervention will be applied after a standardized fatigue protocol consisting of repeated drop jumps, which is identical for all participants. This intervention reflects standard recovery practices commonly used in athletic settings.

Active recovery consists of continuous cycling on a cycle ergometer for 20 minutes at low intensity, not exceeding 2-3 on a 0-10 rating of perceived exertion scale. This intervention is performed after a standardized fatigue protocol and reflects common recovery practices in athletic settings.

Altri nomi:
  • Esercizio ciclistico a bassa intensità

Cosa sta misurando lo studio?

Misure di risultato primarie

Misura del risultato
Misura Descrizione
Lasso di tempo
Countermovement jump height
Lasso di tempo: Baseline (after warm-up), immediately after fatigue protocol, and immediately after intervention (20 minutes).

Vertical jump performance will be assessed using a countermovement jump test. Jump height will be measured using a validated mobile application after three attempts, and the mean value will be recorded.

Baseline (after warm-up), immediately after fatigue protocol, and immediately after intervention (20 minutes).

Misure di risultato secondarie

Misura del risultato
Misura Descrizione
Lasso di tempo
Muscle mechanical properties
Lasso di tempo: Baseline (after warm-up), immediately after fatigue protocol, and immediately after intervention (20 minutes).

Muscle mechanical properties will be assessed using a handheld myotonometer. Parameters will include muscle tone and stiffness measured at standardized anatomical locations of the rectus femoris, vastus lateralis, medial gastrocnemius, and lateral gastrocnemius.

Baseline (after warm-up), immediately after fatigue protocol, and immediately after intervention (20 minutes).
Pressure pain threshold
Lasso di tempo: Baseline (after warm-up), immediately after fatigue protocol, and immediately after intervention (20 minutes).

Pressure pain threshold will be assessed using a handheld algometer. Measurements will be performed at standardized anatomical locations of the rectus femoris, vastus lateralis, and medial gastrocnemius, and the mean of repeated measurements will be recorded.

Baseline (after warm-up), immediately after fatigue protocol, and immediately after intervention (20 minutes).
Rating of perceived exertion
Lasso di tempo: Baseline (after warm-up), immediately after fatigue protocol, immediately after intervention (20 minutes), 12 hours, and 24 hours.

Perceived exertion will be assessed using a 0-10 rating scale, where higher values indicate greater perceived effort.

Baseline (after warm-up), immediately after fatigue protocol, immediately after intervention (20 minutes), 12 hours, and 24 hours.
Delayed-onset muscle soreness.
Lasso di tempo: Baseline (after warm-up), 12 hours, and 24 hours.

Delayed-onset muscle soreness (DOMS) will be assessed using a 0-10 numeric rating scale, where 0 indicates no muscle soreness and 10 indicates the worst possible muscle soreness.

Baseline (after warm-up), 12 hours, and 24 hours.

Collaboratori e investigatori

Qui è dove troverai le persone e le organizzazioni coinvolte in questo studio.

Investigatori

  • Investigatore principale: Sandra Alcaraz Clariana, PhD PT, Maimonides Biomedical Research Institute of Cordoba (IMIBIC). Department of Nursing, Pharmacology and Physical Therapy, Faculty of Medicine and Nursing, University of Córdoba, Córdoba, Spain;

Pubblicazioni e link utili

La persona responsabile dell'inserimento delle informazioni sullo studio fornisce volontariamente queste pubblicazioni. Questi possono riguardare qualsiasi cosa relativa allo studio.

Studiare le date dei record

Queste date tengono traccia dell'avanzamento della registrazione dello studio e dell'invio dei risultati di sintesi a ClinicalTrials.gov. I record degli studi e i risultati riportati vengono esaminati dalla National Library of Medicine (NLM) per assicurarsi che soddisfino specifici standard di controllo della qualità prima di essere pubblicati sul sito Web pubblico.

Studia le date principali

Inizio studio (Effettivo)

27 aprile 2026

Completamento primario (Stimato)

1 dicembre 2026

Completamento dello studio (Stimato)

1 febbraio 2027

Date di iscrizione allo studio

Primo inviato

26 marzo 2026

Primo inviato che soddisfa i criteri di controllo qualità

16 aprile 2026

Primo Inserito (Effettivo)

23 aprile 2026

Aggiornamenti dei record di studio

Ultimo aggiornamento pubblicato (Effettivo)

5 novembre 2026

Ultimo aggiornamento inviato che soddisfa i criteri QC

3 novembre 2026

Ultimo verificato

1 marzo 2026

Maggiori informazioni

Termini relativi a questo studio

Piano per i dati dei singoli partecipanti (IPD)

Hai intenzione di condividere i dati dei singoli partecipanti (IPD)?

NO

Informazioni su farmaci e dispositivi, documenti di studio

Studia un prodotto farmaceutico regolamentato dalla FDA degli Stati Uniti

No

Studia un dispositivo regolamentato dalla FDA degli Stati Uniti

No

Queste informazioni sono state recuperate direttamente dal sito web clinicaltrials.gov senza alcuna modifica. In caso di richieste di modifica, rimozione o aggiornamento dei dettagli dello studio, contattare register@clinicaltrials.gov. Non appena verrà implementata una modifica su clinicaltrials.gov, questa verrà aggiornata automaticamente anche sul nostro sito web .

Sottoscrivi